Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial
Results on Monday, May 9, 2005 


BALTIMORE, May 2  /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc.
(NASDAQ:GLFD) will host a conference call and live audio webcast to announce
its first quarter 2005 financial results on Monday, May 9, 2005, beginning at
4:00 p.m. E.D.T.  During this call, Guilford's management will discuss the
financial results and other business for the upcoming year.

The press release and live webcast can be accessed by going to the Investor
Relations section of Guilford's website at http://www.guilfordpharm.com/. 
Following the webcast, an archived version of the call will be available until
Monday, May 23, 2005.

To participate in the live conference call, U.S. residents should dial
800-706-7749, international callers 617-614-3474.  The participant passcode is
27937394.

An audio replay of the conference call will be available for 48 hours beginning
at approximately 6:00 p.m. E.T. on May 9, 2005 through 6:00 p.m. May 11, 2005. 
To access the replay, U.S. residents should dial 888-286-8010, (int'l callers
617-801-6888), passcode 47441563.

Guilford Pharmaceuticals Inc. is a fully integrated pharmaceutical company
engaged in the research, development and commercialization of products that
target the hospital market.  Presently, Guilford markets two commercial
products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R)
Injection, a glycoprotein GP IIb/IIIa receptor antagonist used for the
treatment of acute coronary syndrome (ACS).  Guilford's product pipeline
includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating
Parkinson's disease and post-prostatectomy erectile dysfunction.

CONTACT:  Stacey Jurchison, Guilford Pharmaceuticals Inc., [phone], . 

DATASOURCE: Guilford Pharmaceuticals Inc.



CONTACT:  Stacey Jurchison, Guilford Pharmaceuticals Inc.,

[phone], 



Web site:  http://www.guilfordpharm.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/112882.html

Copyright